| Dr Prachi Baliram Raut, MBBS | |
|
303 Eagle Hts, Madison, WI 53705-1767 | |
| (514) 920-7406 | |
| Not Available |
| Full Name | Dr Prachi Baliram Raut |
|---|---|
| Gender | Female |
| Speciality | Pathology |
| Experience | 13 Years |
| Location | 303 Eagle Hts, Madison, Wisconsin |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104113653 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ssm Health St Mary's Hospital - Madison | Madison, WI | Hospital |
| Fort Memorial Hospital | Fort atkinson, WI | Hospital |
| Ssm Health St Mary's Hospital - Janesville | Janesville, WI | Hospital |
| Ssm Health St Clare Hospital - Baraboo | Baraboo, WI | Hospital |
| Sauk Prairie Hospital | Prairie du sac, WI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Associated Pathologists, Sc | 9739285479 | 19 |
News Archive
POZEN Inc., announced today the receipt of a $20 million milestone payment from AstraZeneca for the U.S. Food and Drug Administration approval of VIMOVO (naproxen and esomeprazole magnesium) delayed-release tablets on April 30th. POZEN will transfer ownership of the Investigational New Drug application and New Drug Application for VIMOVO to AstraZeneca over the next few weeks.
Gov. Bev Perdue vetoed a bill Monday that would require women seeking abortions to wait 24 hours after state-prescribed counseling, leaving the bill's House supporters looking for override votes. The bill would have made significant changes in state abortion policy, changes supporters said would give pregnant women important information about fetal development and abortion alternatives.
Despite sluggish economic growth and rapidly rising health care costs, Americans' access to needed medical care improved slightly between 2001 and 2003, especially among low-income children and adults, according to a national study released today by the Center for Studying Health System Change (HSC).
Eye-opening research by neurosurgeons from Barrow Neurological Institute and Montreal Neurological Institute has produced the foremost investigation of the origin and evolution of perhaps the most famous concept devised in neurobiology-the homunculus of neurosurgeon Wilder Penfield.
The drug vismodegib (trade name: Erivedge) is approved for the treatment of patients with two forms of basal cell carcinoma: symptomatic metastatic BCC and locally advanced BCC inappropriate for surgery or radiotherapy.
› Verified 4 days ago
| Entity Name | The Monroe Clinic Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1386720548 PECOS PAC ID: 3072425495 Enrollment ID: O20031104000392 |
News Archive
POZEN Inc., announced today the receipt of a $20 million milestone payment from AstraZeneca for the U.S. Food and Drug Administration approval of VIMOVO (naproxen and esomeprazole magnesium) delayed-release tablets on April 30th. POZEN will transfer ownership of the Investigational New Drug application and New Drug Application for VIMOVO to AstraZeneca over the next few weeks.
Gov. Bev Perdue vetoed a bill Monday that would require women seeking abortions to wait 24 hours after state-prescribed counseling, leaving the bill's House supporters looking for override votes. The bill would have made significant changes in state abortion policy, changes supporters said would give pregnant women important information about fetal development and abortion alternatives.
Despite sluggish economic growth and rapidly rising health care costs, Americans' access to needed medical care improved slightly between 2001 and 2003, especially among low-income children and adults, according to a national study released today by the Center for Studying Health System Change (HSC).
Eye-opening research by neurosurgeons from Barrow Neurological Institute and Montreal Neurological Institute has produced the foremost investigation of the origin and evolution of perhaps the most famous concept devised in neurobiology-the homunculus of neurosurgeon Wilder Penfield.
The drug vismodegib (trade name: Erivedge) is approved for the treatment of patients with two forms of basal cell carcinoma: symptomatic metastatic BCC and locally advanced BCC inappropriate for surgery or radiotherapy.
› Verified 4 days ago
| Entity Name | Associated Pathologists, Sc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396782231 PECOS PAC ID: 9739285479 Enrollment ID: O20070426000271 |
News Archive
POZEN Inc., announced today the receipt of a $20 million milestone payment from AstraZeneca for the U.S. Food and Drug Administration approval of VIMOVO (naproxen and esomeprazole magnesium) delayed-release tablets on April 30th. POZEN will transfer ownership of the Investigational New Drug application and New Drug Application for VIMOVO to AstraZeneca over the next few weeks.
Gov. Bev Perdue vetoed a bill Monday that would require women seeking abortions to wait 24 hours after state-prescribed counseling, leaving the bill's House supporters looking for override votes. The bill would have made significant changes in state abortion policy, changes supporters said would give pregnant women important information about fetal development and abortion alternatives.
Despite sluggish economic growth and rapidly rising health care costs, Americans' access to needed medical care improved slightly between 2001 and 2003, especially among low-income children and adults, according to a national study released today by the Center for Studying Health System Change (HSC).
Eye-opening research by neurosurgeons from Barrow Neurological Institute and Montreal Neurological Institute has produced the foremost investigation of the origin and evolution of perhaps the most famous concept devised in neurobiology-the homunculus of neurosurgeon Wilder Penfield.
The drug vismodegib (trade name: Erivedge) is approved for the treatment of patients with two forms of basal cell carcinoma: symptomatic metastatic BCC and locally advanced BCC inappropriate for surgery or radiotherapy.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Prachi Baliram Raut, MBBS 303 Eagle Hts, Madison, WI 53705-1767 Ph: (608) 829-5485 | Dr Prachi Baliram Raut, MBBS 303 Eagle Hts, Madison, WI 53705-1767 Ph: (514) 920-7406 |
News Archive
POZEN Inc., announced today the receipt of a $20 million milestone payment from AstraZeneca for the U.S. Food and Drug Administration approval of VIMOVO (naproxen and esomeprazole magnesium) delayed-release tablets on April 30th. POZEN will transfer ownership of the Investigational New Drug application and New Drug Application for VIMOVO to AstraZeneca over the next few weeks.
Gov. Bev Perdue vetoed a bill Monday that would require women seeking abortions to wait 24 hours after state-prescribed counseling, leaving the bill's House supporters looking for override votes. The bill would have made significant changes in state abortion policy, changes supporters said would give pregnant women important information about fetal development and abortion alternatives.
Despite sluggish economic growth and rapidly rising health care costs, Americans' access to needed medical care improved slightly between 2001 and 2003, especially among low-income children and adults, according to a national study released today by the Center for Studying Health System Change (HSC).
Eye-opening research by neurosurgeons from Barrow Neurological Institute and Montreal Neurological Institute has produced the foremost investigation of the origin and evolution of perhaps the most famous concept devised in neurobiology-the homunculus of neurosurgeon Wilder Penfield.
The drug vismodegib (trade name: Erivedge) is approved for the treatment of patients with two forms of basal cell carcinoma: symptomatic metastatic BCC and locally advanced BCC inappropriate for surgery or radiotherapy.
› Verified 4 days ago
Megan Fitzpatrick, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 3617 Odana Rd, Madison, WI 53711 Phone: 575-770-2064 | |
Lixia Bai, MD, PH.D Pathology Medicare: Medicare Enrolled Practice Location: 600 Highland Ave, Madison, WI 53792 Phone: 608-263-6400 | |
Deborah Turski, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 707 S Mills St, Madison, WI 53715 Phone: 608-251-6100 Fax: 608-826-2710 | |
Dr. Kristina Ann Matkowskyj, MD, PHD Pathology Medicare: Accepting Medicare Assignments Practice Location: 600 Highland Ave, Madison, WI 53792 Phone: 608-263-8443 Fax: 608-262-7174 | |
Yang Zong, Pathology Medicare: Medicare Enrolled Practice Location: 600 Highland Ave, Madison, WI 53792 Phone: 608-263-8443 | |
Ricardo V Lloyd, M.D. Pathology Medicare: Medicare Enrolled Practice Location: 600 Highland Ave, Madison, WI 53792 Phone: 608-263-8443 | |
Chen Kang Chang, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 707 S Mills St, Madison, WI 53715 Phone: 608-251-6100 Fax: 608-826-2710 |